ICM
RANI icon

Islay Capital Management’s Rani Therapeutics RANI Stock Holding History

Islay Capital Management’s Portfolio RANI Stock Details RANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.06K Hold
9,611
– – ﹤0.01% 169
2025
Q4 		$13K Hold
9,611
– – 0.01% 163
2025
Q3 		$4.8K Hold
9,611
– – ﹤0.01% 183
2025
Q2 		$4.94K Hold
9,611
– – ﹤0.01% 166
2025
Q1 		$12.1K Hold
9,611
– – 0.01% 146
2024
Q4 		$13.2K Hold
9,611
– – 0.01% 155
2024
Q3 		$20.8K Hold
9,611
– – 0.01% 147
2024
Q2 		$36.5K Hold
9,611
– – 0.03% 135
2024
Q1 		$29.9K Hold
9,611
– – 0.02% 143
2023
Q4 		$31.9K Hold
9,611
– – 0.02% 151
2023
Q3 		$20.9K Hold
9,611
– – 0.02% 157
2023
Q2 		$39.6K Hold
9,611
– – 0.03% 133
2023
Q1 		$49.6K Hold
9,611
– – 0.05% 131
2022
Q4 		$56.7K Hold
9,611
– – 0.07% 123
2022
Q3 		$92K Hold
9,611
– – 0.11% 108
2022
Q2 		$99K Buy
+9,611
New +$110K 0.1% 134

Other funds holding RANI

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCP
SymBiosis Capital Partners Bentonville, Arkansas $52.8M AUM
LP
Longaeva Partners Chicago, Illinois $2.7B AUM 37.16% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return

Islay Capital Management's RANI Position: Q1 2026 in Review

Islay Capital Management held its Rani Therapeutics (RANI) position steady in Q1 2026 at 9,611 shares worth $7.06K. The position accounts for ﹤0.01% of the portfolio, ranked #169.

Islay Capital Management first reported a position in RANI in Q2 2022 and has held it in 16 quarters since. The position peaked at $99K in Q2 2022. 74 funds tracked by Wall St. Rank hold RANI as of Q1 2026.

  • Islay Capital Management held 9,611 shares of Rani Therapeutics worth $7.06K as of Q1 2026.
  • Islay Capital Management left its Rani Therapeutics share count unchanged in Q1 2026.
  • Rani Therapeutics made up ﹤0.01% of Islay Capital Management's portfolio in Q1 2026, its #169 holding.
  • Islay Capital Management first reported a position in Rani Therapeutics in Q2 2022 and has held it in 16 quarters since.
  • Islay Capital Management's Rani Therapeutics position peaked at $99K in Q2 2022.
  • 74 funds tracked by Wall St. Rank held Rani Therapeutics as of Q1 2026.

Based on Islay Capital Management's 13F filing for Q1 2026, filed 14 May 2026.